These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 27255888)

  • 21. Multiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis.
    Brink M; Hansson M; Mathsson L; Jakobsson PJ; Holmdahl R; Hallmans G; Stenlund H; Rönnelid J; Klareskog L; Rantapää-Dahlqvist S
    Arthritis Rheum; 2013 Apr; 65(4):899-910. PubMed ID: 23310951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic background of anticyclic citrullinated peptide autoantibody production in Hungarian patients with rheumatoid arthritis.
    Poór G; Nagy ZB; Schmidt Z; Brózik M; Merétey K; Gergely P
    Ann N Y Acad Sci; 2007 Sep; 1110():23-32. PubMed ID: 17911417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-citrullinated peptides as autoantigens in rheumatoid arthritis-relevance to treatment.
    Sakkas LI; Bogdanos DP; Katsiari C; Platsoucas CD
    Autoimmun Rev; 2014 Nov; 13(11):1114-20. PubMed ID: 25182207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies to carbamylated α-enolase epitopes in rheumatoid arthritis also bind citrullinated epitopes and are largely indistinct from anti-citrullinated protein antibodies.
    Reed E; Jiang X; Kharlamova N; Ytterberg AJ; Catrina AI; Israelsson L; Mathsson-Alm L; Hansson M; Alfredsson L; Rönnelid J; Lundberg K
    Arthritis Res Ther; 2016 May; 18(1):96. PubMed ID: 27145822
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Massarenti L; Enevold C; Damgaard D; Ødum N; Garred P; Frisch M; Shelef MA; Jacobsen S; Nielsen CH
    Front Immunol; 2021; 12():707690. PubMed ID: 34733271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional haplotypes of PADI4: relevance for rheumatoid arthritis specific synovial intracellular citrullinated proteins and anticitrullinated protein antibodies.
    Cantaert T; Coucke P; De Rycke L; Veys EM; De Keyser F; Baeten D
    Ann Rheum Dis; 2005 Sep; 64(9):1316-20. PubMed ID: 15760928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An increased concentration of receptor activator of nuclear factor kappa-B ligand pre-dates the onset of rheumatoid arthritis.
    Johansson L; Ärlestig L; Kokkonen H; Brink M; Rantapää-Dahlqvist S
    Rheumatology (Oxford); 2017 Dec; 56(12):2190-2196. PubMed ID: 29029341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivities.
    Ioan-Facsinay A; el-Bannoudi H; Scherer HU; van der Woude D; Ménard HA; Lora M; Trouw LA; Huizinga TW; Toes RE
    Ann Rheum Dis; 2011 Jan; 70(1):188-93. PubMed ID: 20736390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies.
    Jiang X; Trouw LA; van Wesemael TJ; Shi J; Bengtsson C; Källberg H; Malmström V; Israelsson L; Hreggvidsdottir H; Verduijn W; Klareskog L; Alfredsson L; Huizinga TW; Toes RE; Lundberg K; van der Woude D
    Ann Rheum Dis; 2014 Oct; 73(10):1761-8. PubMed ID: 24812286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature.
    Bartoloni E; Alunno A; Bistoni O; Bizzaro N; Migliorini P; Morozzi G; Doria A; Mathieu A; Lotzniker M; Allegri F; Riccieri V; Alpini C; Gabrielli A; Tampoia M; Gerli R;
    Autoimmun Rev; 2012 Sep; 11(11):815-20. PubMed ID: 22394488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis.
    Szodoray P; Szabó Z; Kapitány A; Gyetvai A; Lakos G; Szántó S; Szücs G; Szekanecz Z
    Autoimmun Rev; 2010 Jan; 9(3):140-3. PubMed ID: 19427413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of Autoantigens Targeted by Anti-Citrullinated Protein Antibodies In Vivo: Prominent Role for Epitopes Derived from Histone 4 Proteins.
    Meng X; Ezzati P; Smolik I; Bernstein CN; Hitchon CA; El-Gabalawy HS
    PLoS One; 2016; 11(10):e0165501. PubMed ID: 27788229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of autoantibodies against citrullinated antigens/peptides by human B cells.
    Bellatin MF; Han M; Fallena M; Fan L; Xia D; Olsen N; Branch V; Karp D; Stastny P
    J Immunol; 2012 Apr; 188(7):3542-50. PubMed ID: 22345652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies to native and citrullinated RA33 (hnRNP A2/B1) challenge citrullination as the inciting principle underlying loss of tolerance in rheumatoid arthritis.
    Konig MF; Giles JT; Nigrovic PA; Andrade F
    Ann Rheum Dis; 2016 Nov; 75(11):2022-2028. PubMed ID: 26865600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein/peptide antibody fine specificity profile.
    Lundberg K; Bengtsson C; Kharlamova N; Reed E; Jiang X; Kallberg H; Pollak-Dorocic I; Israelsson L; Kessel C; Padyukov L; Holmdahl R; Alfredsson L; Klareskog L
    Ann Rheum Dis; 2013 May; 72(5):652-8. PubMed ID: 22661643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-citrullinated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients.
    Barra L; Scinocca M; Saunders S; Bhayana R; Rohekar S; Racapé M; Coles R; Cairns E; Bell DA
    Arthritis Rheum; 2013 Jun; 65(6):1439-47. PubMed ID: 23450693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis.
    Berglin E; Padyukov L; Sundin U; Hallmans G; Stenlund H; Van Venrooij WJ; Klareskog L; Dahlqvist SR
    Arthritis Res Ther; 2004; 6(4):R303-8. PubMed ID: 15225365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular basis for increased susceptibility of Indigenous North Americans to seropositive rheumatoid arthritis.
    Scally SW; Law SC; Ting YT; Heemst JV; Sokolove J; Deutsch AJ; Bridie Clemens E; Moustakas AK; Papadopoulos GK; van der Woude D; Smolik I; Hitchon CA; Robinson DB; Ferucci ED; Bernstein CN; Meng X; Anaparti V; Huizinga T; Kedzierska K; Reid HH; Raychaudhuri S; Toes RE; Rossjohn J; El-Gabalawy H; Thomas R
    Ann Rheum Dis; 2017 Nov; 76(11):1915-1923. PubMed ID: 28801345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-HLA genes PTPN22, CDK6 and PADI4 are associated with specific autoantibodies in HLA-defined subgroups of rheumatoid arthritis.
    Snir O; Gomez-Cabrero D; Montes A; Perez-Pampin E; Gómez-Reino JJ; Seddighzadeh M; Klich KU; Israelsson L; Ding B; Catrina AI; Holmdahl R; Alfredsson L; Klareskog L; Tegnér J; Gonzalez A; Malmström V; Padyukov L
    Arthritis Res Ther; 2014 Aug; 16(4):414. PubMed ID: 25138370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fine specificity of anti-citrullinated peptide antibodies discloses a heterogeneous antibody population in rheumatoid arthritis.
    Goules JD; Goules AV; Tzioufas AG
    Clin Exp Immunol; 2013 Oct; 174(1):10-7. PubMed ID: 23711220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.